Coronary Stent Market Size, Share, Growth, Application Analysis, Trends and Forecast Report
by Susan Hill Business ConsultantThe
global coronary stents market is expected to reach USD 15.18
billion by 2024, according to a new report by Grand View Research, Inc. Rising
prevalence of coronary artery diseases, supportive government reforms and
increasing awareness are contributing factors for lucrative growth of coronary
stents
The latest
treatments available in cardiac care are expected to increase the life span of
the elderly population subset. This demographic is characterized with low
immunity levels and are prone to chronic diseases including CVDs. Thus, increasing
geriatric population is thereby considered as a high impact rendering driver
for the growth of this industry over the forecast period.
The coronary
stent market is driven by reimbursement coverage provided by the general public
Center for Medicare & Medicaid Services (CMS) and private payers. The
coverage is availed under national coverage determination for carotid artery
stenting, including products and service provider. The providers require
completing certain conditions for coverage, all facilities to be certified by
CMS to perform CAS procedures.
Grasp advance
knowledge on global coronary stent industry through in-depth research insights:
https://www.grandviewresearch.com/research-insights/coronary-stents-market-biodegradable-stents-expected-to-grow-progressively
Reimbursement
of medical devices is limited to the developed regions of Asia Pacific. For
instance, Japan’s National Health Insurance system provides reimbursement for
all medical devices. However, some countries in the Asia Pacific region have no
scope for reimbursement and the patients themselves incur the expenses while
the unprivileged ones often forego treatment, thus restraining the growth of
this vertical in certain countries.
Further key
findings from the study suggest:
- DES held
lucrative share in 2015. Avoidance of complications, ease of procedures
and comfort to the patient are factors responsible for increased usage
rate.
- BVS are
anticipated to growth exponential over the forecast period due to the
added advantages such as restoring vasomotor function, and fewer
complications offered by the product.
- North America
held substantial share in global coronary stents market. Sophisticated
healthcare system, well planned reimbursement program, high healthcare
expenditure and large pool of target population are responsible for the
region’s substantial share.
- Asia Pacific is
anticipated to exhibit lucrative growth over the forecast period. Economic
developments and government reforms especially in countries like India and
China are supporting the growth of this region.
Grand View
Research has segmented the coronary stents market on the basis of product and
region:
Global Coronary
Stents Product Outlook (Revenue, USD Million, 2013 - 2024)
- Bare Metal
Stents (BMS)
- Drug Eluting
Stents
- Biodegradable
- Non-Biodegradable
- Bioresorbable
Vascular Scaffold (BVS)
Coronary Stents
Regional Outlook (Revenue, USD Million, 2013 - 2024)
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Sponsor Ads
Created on Aug 22nd 2019 08:30. Viewed 411 times.